SUMMARY Clinical investigations of the usefulness of routine epidemiological treatment of sexual contacts of men with non-gonococcal urethritis (NGU) have produced conflicting results that could have been due to the selection of patients. In this study, which was undertaken in a provincial city, 100 men with untreated sexual partners and 100 demographically similar men with treated sexual partners were reviewed for recurrences of NGU over 12 months. Prolonged courses of tetracyclines were found to be beneficial particularly when the sexual partner gave positive results to tests for chlamydiae. There was, however, no clinical evidence that the men benefited from routine epidemiological treatment of their sexual partners.
Introduction
Non-gonococcal urethritis (NGU) continues to be difficult to define and to treat, in spite of advances in the understanding of the aetiological role of Chiamydia trachomatis and mycoplasmas. The number of cases reported yearly in men continues to rise, and increased in the United Kingdom from 59 023 in 19711 to 86 8% in 1981.2 This implies the existence of an increasing reservoir of infection in the female population. As there is little agreement on the clinical features of non-specific genital infection (NSGI) in women, however, treatment is frequently offered on an epidemiological basis-that is, to sexual contacts without or before confirmation that they are infected.3 Such treatment is given in 76 3% of clinics in the United Kingdom, although in only 54% of these is it given to most patients. This is because of differing opinions of the value of epidemiological treatment and the few investigations performed since tetracyclines became the almost universal treatment for non-specific urethritis (NSU) came to contradictory conclusions.4' Not all these studies were able to surmount certain practical difficulties of trial design: patients with previous urethritis need to be excluded, as a salient feature of the disease is its chronicity; all patients must have taken at least part of their treatment simultaneously with their sexual partners to prevent immediate re-infection; and the relevance of default from follow up must be assessed.
Routine The female sexual partners all had a genital examination, which included inspection of the cervix and vagina using a speculum and bimanual pelvic examination. The following tests were carried out routinely: microscopy of smears from the urethra and endocervical canal; culture of swabs from the urethra and cervix for N gonorrhoeae; dark ground microscopy of vaginal wet mount preparations for T vaginalis and yeast; and (in 1980) culture of swabs from the cervix for C trachomatis. In addition full blood counts and serological tests for syphilis were performed routinely. Specimens for isolation of C trachomatis were transported in a medium containing sorbitol, vancomycin, streptomycin, and mycostatin, inoculated into monolayers of McCoy cells sterilised with idoxuridine, and grown on coverslips in flat bottomed tubes. Inoculation was achieved by centrifuging at 3000 x g for one hour at 35°C and was followed by incubation at 17°C for 48 hours in a maintainance medium with added amphotericin B. Cells were then fixed in methanol, stained with Giemsa, and examined for inclusion bodies by dark ground microscopy. TREATMENT Women in whom no specific organism had been found by the microscopical methods described above were treated routinely as contacts of men with NSU. Almost all received triple tetracycline (Deteclo 300 mg) (Lederle, Gosport, Hampshire) twice daily for two weeks, or the same dose of erythromycin if pregnancy was a possibility. (One 300 mg tablet of Deteclo contains chlortetracycline hydrochloride 115-4 mg, tetracycline hydrochloride 115-4 mg, demeclocycline hydrochloride 69-2 mg; erythromycin was given as Erythrocin 500 (Abbott, Queenborough, Kent)).
The men were all offered three weeks' treatment, the tablets being dispensed at weekly visits to check on response and assist compliance, but naturally some men defaulted before they had received the whole course. Nearly all were treated with tetracyclines, most with triple tetracycline, although if the immediate response was unsatisfactory a change of antibiotic was made. Of the patients seen in 1978, 93 were treated with triple tetracycline, and seven with oxytetracycline; of those seen in in 1980, 91 were treated with triple tetracycline, eight with oxytetracycline, and one with erythromycin. Of the patients treated with triple tetracycline, three of those seen in 1978 and six of those seen in 1980 were later treated with oxytetracycline or erythromycin.
FOLLOW UP
The follow up after the end of treatment depended on the circumstances of the individual case, most patients being asked to reattend after two weeks and then after two months. Nevertheless, for reasons given earlier, it was assumed that patients who had further symptoms would reattend the clinic for assessment. The case records of all the patients were therefore examined for 12 months after the start of treatment, and their subsequent progress was analysed. To make comparisons with other work possible, the index of relapse or reinfection used was "recurrence requiring retreatment", in common with most other studies of NSU.4-69 10 The average total attendance at the clinic was 20 "casual" relationship and four (13%) of them required treatment at three months; whereas 65 were in a "regular" relationship and seven (11I%) of them required treatment. (The status of the four other patients was not known.) Table II shows that in both groups of men similar numbers had had more than one sexual contact in the six weeks before initial treatment, and that this had an appreciable bearing on the numbers of recurrences. Retreatment rates (12-5% in 1978, 31% in 1980) were higher in patients over 40 and men of West Indian origin (16% in 1978, 43% in 1980), but the numbers in these categories were too small to allow clear conclusions to be drawn. Patients who were given short courses of treatment were much more likely to require retreatment, whether their contacts were treated or not. Of men seen in 1978, six (21 %) out of the 28 patients given one or two weeks' treatment required further treatment within three months, compared with 7% of those treated for three weeks. The corresponding figures for men seen in 1980 was three (18%) out of 17 compared with 7% of those treated for three weeks. By 1980, routine culture for C trachomatis had become available, and 29% of the 100 men studied had a contact from whom it was isolated. In the first three months, only one of these men (3-5%) required retreatment, and he had had a new sexual partner. This compares with seven (10%) out of 71 men in whom C trachomatis was not isolated. Discussion Although the tracing and treatment of sexual contacts is an axiom in the treatment of most sexually transmitted infections, some workers still do not feel that it is necessary in NGU. The evidence for its being beneficial is scanty, and the studies done have been difficult to evaluate for the reasons mentioned earlier. This study also failed to show clear cut evidence that men benefit substantially from routine epidemiological treatment of their female sexual partners and confirms the conclusions of Evans 
